Veteran Oncologist and Clinical Development expert to lead global medical strategy supporting patient-focused drug development and deliveryDURHAM, N.C., April 15,…
This innovative tech collaboration addresses emotional, logistical and financial challenges associated with international clinical trial recruitment, accelerating access to groundbreaking…
WELL achieved annual revenue of $919.7 million in 2024, an increase of 19% compared to the prior year. Under applicable…
DELRAY BEACH, Fla., April 14, 2025 /PRNewswire/ -- The US Clinical Communication & Collaboration Market is expected to reach US$1.57 billion by…
NEW YORK, April 14, 2025 /PRNewswire/ -- Medication non-adherence is a significant and preventable challenge in healthcare, contributing to an…
Research to explore Promino's patented amino acid blend in addressing treatment-related muscle wasting in two of the most prevalent cancers…
— Innovative ethanol-free formulation intended to provide improved safety and advance care for patients undergoing high-dose conditioning therapy prior to…
Pediatric Patient Treated with OneRF® Ablation System Goes From Up to 10 Nightly Seizures to Zero EDEN PRAIRIE, Minn., April…
Châtillon, France, April 11, 2025 DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document…
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company” or “NanoVibronix”), a medical technology company specializing in non-invasive therapeutic devices, today…